Symphony IL-6 test for sepsis in the emergency room
Part of Infections clinical trials.
This trial checks if a new blood test (Symphony IL-6) can help doctors quickly identify sepsis in patients coming to the emergency room. It may speed up diagnosis and treatment for serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 22 years old or older
- You are being admitted to the hospital from the emergency room
- You can have a blood sample taken within 12 hours of arriving at the ER
- You have signs of infection (like fever, fast heart rate, or a culture ordered)
- You are not in prison, pregnant, or already enrolled in this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test called the Sepsis ImmunoScore that may help doctors quickly identify sepsis (a life-threatening infection response). The test looks at your immune system's response to see if you have sepsis, which could help you get treatment faster.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This study tests whether a special blood test can help doctors quickly identify patients who have serious infections (sepsis) in the emergency department. The test looks at white blood cells that glow under fluorescent light to see if they can predict which patients are at highest risk.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
Hear when a new Sepsis, Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.